| |
Significant Biomarkers
|
Physiological Processes
|
|---|
|
Asthma
|
Platelet Count
|
Thrombogenesis
|
| |
Serum Sodium
|
Serum sodium
|
| |
ALT
|
Tissue injury
|
| |
Neutrophil Percent
|
Acute inflammation
|
|
Type 1 Diabetes
|
Serum Sodium
|
Serum sodium
|
| |
Blood Urea Nitrogen
|
Kidney function
|
| |
Platelet Count
|
Thrombogenesis
|
| |
TSH3
|
Thyroid function
|
|
Type 2 Diabetes
|
Serum Sodium
|
Serum sodium
|
| |
ALT
|
Tissue injury
|
| |
Platelet Count
|
Thrombogenesis
|
|
Duchenne Muscular Dystrophy
|
Lactate Dehydrogenase
|
Tissue injury
|
| |
Triglycerides
|
Lipogenesis
|
| |
Platelet Count
|
Thrombogenesis
|
| |
AST
|
Tissue injury
|
|
Cystic Fibrosis
|
Total IgE
|
IgE antibody response
|
| |
Alkaline Phosphatase
|
Dephosphorylation
|
| |
Platelet Count
|
Thrombogenesis
|
- Significant biomarkers for each disease are shown. Each significant biomarker was identified as a significant and statistically independent physiological factor from the patient laboratory data by ICA analysis (see Methods). Each significant biomarker was matched to a broader physiological process using a standard reference for clinical laboratory chemistry.
